Xponential Fitness lowered its 2026 revenue guidance to $250-$260 million and EBITDA to $91-$97 million due to weaker sales and slower studio expansion. UBS also cut its revenue and EBITDA estimates for 2026 and 2027, citing weaker same-store sales and tougher lease negotiations. The company faces challenges from merchandise sourcing issues and expects $11.4 million in legal settlement costs in H2 2026. Despite setbacks, management highlights 8% fitness market growth and rising participation among younger consumers.
Xponential Fitness outlook is reported here with Pluang's Consumer Cyclical sector data as context. For readers following this sector, as of Sep 17, 2026 22:22 WIB, 64 of 105 priced US stocks rose while 40 fell. Notable movers include LCID at USD 4.38 with a 1-day change of +8.42% and 100% buy order activity, QS at USD 5.25 with a 1-day change of +4.90% and 97% sell order activity, and VSXY at USD 77.32 with a 1-day change of +4.54%.
The global clinical trial supplies market is projected to grow from $5.7 billion in 2025 to $10.7 billion by 2033, at an 8.4% CAGR. This growth is driven by increased R&D investments, rising chronic diseases, and the expansion of biologics, personali...
Starlink Mobile, launched by VEON Ltd. across Ukraine, Kazakhstan, and Bangladesh, has connected over 11 million users in less than a year. The service enables existing 4G phones to access satellite connectivity where terrestrial signals are unavaila...
Medallion Financial Corp. announced it will repurchase $15 million in trust preferred securities from BIMIZCI Fund LLC at 73.66% of face value, costing about $11.05 million plus accrued distributions. This deal includes a five-year standstill agreeme...
Belite Bio, a clinical-stage drug developer focused on retinal diseases, has been approved to move its stock listing from the Nasdaq Capital Market to the Nasdaq Global Select Market, the highest tier on Nasdaq. This uplisting reflects the company's ...
Heineken N.V. has repurchased a total of 8,865,521 shares under the second tranche of its €1.5 billion share buyback program, spending €629.4 million as of October 16, 2026. This includes shares bought on the exchange and from Heineken Holding N.V. T...
